# Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism

> **NCT00776191** · PHASE4 · TERMINATED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 5 (actual)

## Conditions studied

- Endstage Renal Disease

## Interventions

- **DRUG:** Physioneal 35
- **DRUG:** Physioneal 40

## Key facts

- **NCT ID:** NCT00776191
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** al study sites stoped on 15/05/2012 because of insufficient recrutement.
- **Last updated:** 2015-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00776191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00776191, "Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00776191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*